Back to results
US 2020/0368316 A1Published application
Methods and compositions for preventing or treating cancer
AssigneesUniversity of Utah Research Foundation, Technion Research & Development Foundation Limited
InventorsJoshua Schiffman, Avi Schroeder, Lisa Abegglen
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to methods and compositions for inhibiting a cancer cell using nucleic acid sequences encoding elephant p53 or elephant p53 amino acid sequences.
Claims22
-34. (canceled)
A composition comprising a pharmaceutically acceptable carrier and (a) one or more nucleic acids each having a sequence encoding an elephant p53 protein, selected from the group consisting of SEQ ID NO:
- 2, SEQ ID NO:
- 12, SEQ ID NO:
- 20 and combinations thereof, or (b) one or more elephant p53 proteins each having a sequence selected from the group consisting of SEQ ID NO:
- 3, SEQ ID NO:
- 13, SEQ ID NO:
- 21 and combinations thereof.
3 more elements
Dependencies are inferred from the claim text.